Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells 11,581 Shares of Stock

Hims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock in a transaction on Monday, February 10th. The shares were sold at an average price of $43.01, for a total value of $498,098.81. Following the completion of the transaction, the chief financial officer now owns 107,789 shares of the company’s stock, valued at approximately $4,636,004.89. The trade was a 9.70 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Oluyemi Okupe also recently made the following trade(s):

• On Tuesday, February 4th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $38.92, for a total value of $450,732.52.
• On Monday, January 13th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The shares were sold at an average price of $24.44, for a total value of $283,039.64.
• On Thursday, December 26th, Oluyemi Okupe sold 4,213 shares of Hims & Hers Health stock. The shares were sold at an average price of $29.98, for a total value of $126,305.74.
• On Friday, December 20th, Oluyemi Okupe sold 18,959 shares of Hims & Hers Health stock. The shares were sold at an average price of $25.77, for a total value of $488,573.43.
• On Monday, November 25th, Oluyemi Okupe sold 101,993 shares of Hims & Hers Health stock. The shares were sold at an average price of $29.62, for a total value of $3,021,032.66.
• On Wednesday, November 13th, Oluyemi Okupe sold 142,886 shares of Hims & Hers Health stock. The stock was sold at an average price of $29.93, for a total value of $4,276,577.98.

Hims & Hers Health Stock Performance

NYSE:HIMS traded down $1.21 on Tuesday, reaching $43.56. The company’s stock had a trading volume of 7,309,816 shares, compared to its average volume of 11,847,643. Hims & Hers Health, Inc. has a 1-year low of $9.14 and a 1-year high of $46.01. The firm has a market cap of $9.52 billion, a PE ratio of 99.01 and a beta of 1.35. The business’s 50-day moving average price is $30.50 and its two-hundred day moving average price is $23.43.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Piper Sandler boosted their target price on Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Needham & Company LLC boosted their target price on Hims & Hers Health from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Bank of America downgraded Hims & Hers Health from a “buy” rating to an “underperform” rating and dropped their target price for the stock from $32.00 to $18.00 in a research report on Thursday, November 14th. BTIG Research assumed coverage on Hims & Hers Health in a research report on Tuesday, January 7th. They set a “buy” rating and a $35.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a report on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Hims & Hers Health currently has an average rating of “Hold” and a consensus price target of $25.13.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. United Services Automobile Association acquired a new position in shares of Hims & Hers Health during the fourth quarter worth about $295,000. Vanguard Group Inc. boosted its position in shares of Hims & Hers Health by 11.1% during the fourth quarter. Vanguard Group Inc. now owns 20,257,116 shares of the company’s stock worth $489,817,000 after buying an additional 2,020,722 shares during the period. LPL Financial LLC boosted its position in shares of Hims & Hers Health by 1.0% during the fourth quarter. LPL Financial LLC now owns 97,958 shares of the company’s stock worth $2,369,000 after buying an additional 980 shares during the period. KLP Kapitalforvaltning AS acquired a new position in shares of Hims & Hers Health during the fourth quarter worth about $861,000. Finally, American Century Companies Inc. boosted its position in shares of Hims & Hers Health by 8.8% during the fourth quarter. American Century Companies Inc. now owns 140,758 shares of the company’s stock worth $3,404,000 after buying an additional 11,425 shares during the period. 63.52% of the stock is owned by institutional investors and hedge funds.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.